Leading Geneticist and Neurodegenerative Disease Researcher, Tatiana Foroud, PhD, Recognized with the 2026 Robert A. Pritzker Prize

Leading Geneticist and Neurodegenerative Disease Researcher, Tatiana Foroud, PhD, Recognized with the 2026 Robert A. Pritzker Prize

PR Newswire

NEW YORK, Nov. 16, 2026 /PRNewswire/ — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded the 2026 Robert A. Pritzker Prize for Leadership in Parkinson’s Research to Tatiana Foroud, PhD, a distinguished professor and Executive Associate Dean for Research Affairs at the Indiana University School of Medicine. The prize recognizes researchers who make exceptional contributions to Parkinson’s disease (PD) research and are committed to mentoring the next generation of Parkinson’s scientists. 

Katherine Kopil, PhD, Senior Vice President and Head of Clinical Research at The Michael J. Fox Foundation (left), presents Tatiana Foroud, PhD (right), with the Robert A. Pritzker Prize for Leadership in Parkinson’s Research.

Dr. Tatiana Foroud is being honored for her exceptional leadership in building the collaborative systems that allow genetic and biomarker discoveries to move toward more precise approaches in Parkinson’s research and therapeutic development. At Indiana University, Dr. Foroud leads several major biorepository efforts that are critical partners to Parkinson’s research and related disorders. Dr. Foroud has played a longstanding role in MJFF’s landmark study, the Parkinson’s Precision Medicine Initiative (PPMI), serving on its executive steering committee and as its genetics chair. She has also played a central role in stewarding PPMI’s biosample resources, helping ensure that samples collected across the study can be used consistently alongside genetic, clinical and biomarker data to deepen understanding of Parkinson’s biology. In these roles, Dr. Foroud has helped shape the study and its efforts to identify people at increased risk for Parkinson’s and determine who may be invited for more in-depth imaging, clinical and biomarker assessments.

“Dr. Foroud’s expertise has been critical in helping us launch into this next era of precision medicine for Parkinson’s,” said Katie Kopil, PhD, senior vice president, head of clinical research at MJFF. “She’s helped pioneer our understanding of genetics and underlying biology that contribute to Parkinson’s, while bringing more people into research as partners. Through her mentorship, Dr. Foroud’s impact is bringing all of us closer to our mission —and makes this honor especially well deserved.”

Kopil presented the award to Foroud during MJFF’s Fall 2026 Research Roundtable in New York City, held in conjunction with the Foundation’s annual gala. The event brought together patients and families to hear more on the Foundation’s strategic research agenda, with discussions led by MJFF scientific leadership. 

Since receiving her first MJFF grant in 2005, Dr. Foroud has helped build the research infrastructure needed to study Parkinson’s genetics and biology at scale. A statistical geneticist by training, she has investigated common and rare genetic variants associated with disease risk, including familial forms of Parkinson’s. This work helps researchers study biologically defined groups and advance more precise approaches to the disease. By building large, standardized collections of biological samples linked to clinical and genetic data, Dr. Foroud has helped give researchers the resources needed to identify and validate biomarkers that can better define Parkinson’s biology.

One key example of this work is Dr. Foroud’s effort to advance quantitative biomarkers that could show not only whether Parkinson’s-related biology is present, but how it changes over time. At Indiana University, she co-leads an MJFF-funded team working to validate a skin-based test that uses alpha-synuclein seed amplification to measure the misfolded protein. More precise measurements could help researchers track disease biology and assess whether a therapy is affecting its intended target.

Dr. Foroud also leads National Institutes of Health and foundation-supported biorepositories, including the National Institute of Neurological Disorders and Stroke-supported BioSEND repository and the Parkinson’s Foundation supported PD GENEration. These resources promote consistent sample handling across studies and support reliable genetic and biomarker research.

“I’m so honored to receive the 2026 Robert A. Pritzker Award for Leadership in Parkinson’s Research and will continue to work toward improving the lives of individuals living with Parkinson’s and those who may be at risk,” said Dr. Foroud. “Seeing the tremendous progress taking place through our shared vision to change the trajectory of the disease continues to push us all forward.” 

The Robert A. Pritzker Prize for Leadership in Parkinson’s Research was established in 2011 by Karen Pritzker and her late husband, Michael Vlock, to honor Karen’s father, Robert A. Pritzker, a renowned industrialist and philanthropist who lived with Parkinson’s. The prize includes a $200,000 research grant and is awarded annually by MJFF’s Scientific Advisory Board. 

Past recipients include Bastiaan Bloem, MD, PhD; Claudio Soto, PhD; Dario Alessi, PhD; J. Timothy Greenamyre, MD, PhD; Glenda Margaret Halliday, PhD; Caroline Tanner, MD, PhD; Andrew Singleton, PhD; Virginia Man-Yee Lee, PhD; Ken Marek, MD; Ira Shoulson, MD; John Hardy, PhD; Heiko Braak, MD; Alim-Louis Benabid, MD, PhD; J. William Langson, MD and Anders Björklund, MD, PhD.

The award sculpture, designed by artist and Parkinson’s patient Tom Shannon, was presented at the Foundation’s annual Research Roundtable in New York City. 

Watch the “Robert A. Pritzker Prize for Leadership in Parkinson’s Research: Meet The Michael J. Fox Foundation’s 2026 Pritzker Prize Winner – YouTube

About the Robert A. Pritzker Prize for Leadership in Parkinson’s Research
The Robert A. Pritzker Prize for Leadership in Parkinson’s Research is named in honor of the late Robert A. Pritzker, a renowned industrialist, entrepreneur and philanthropist. Pritzker was founder of The Marmon Group and president of Colson Associates, Inc., holding companies for a variety of manufacturing and medical businesses. Additionally, he was an early promoter of the field of medical engineering at his alma mater, the Illinois Institute of Technology (IIT) in Chicago, where he also played a key role in expanding the biomedical research community through his support of The Pritzker Institute for Biomedical Science and Engineering at IIT.

The MJFF Scientific Advisory Board serves as the jury panel. Selection criteria include the nominee’s complete body of work in the PD field with an emphasis on its impact on accelerating drug development; field-wide impact of the nominee’s work; dedication to patient-relevant science; and influence on and encouragement of the next generation of PD investigators. The award itself is designed by renowned artist and Parkinson’s patient Tom Shannon.

About The Michael J. Fox Foundation for Parkinson’s Research
As the world’s largest nonprofit funder of Parkinson’s research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson’s disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson’s patients, business leaders, clinical trial participants, donors, and volunteers. In addition to funding $3 billion in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson’s research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; creates a robust open-access data set and biosample library to speed scientific breakthroughs and treatment with its landmark clinical study, PPMI; increases the flow of participants into Parkinson’s disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson’s awareness through high-profile advocacy, events, and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world. For more information, visit us at www.michaeljfox.org, Facebook, Twitter, LinkedIn.

The Michael J. Fox Foundation for Parkinson's Research Logo

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/leading-geneticist-and-neurodegenerative-disease-researcher-tatiana-foroud-phd-recognized-with-the-2026-robert-a-pritzker-prize-302940520.html

SOURCE The Michael J. Fox Foundation for Parkinson’s Research